Jump to content

1DD-LSD: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
Created page with '{{Drugbox | IUPAC_name = (6a''R'',9''R'')-''N'',''N''-diethyl-6-methyl-4-dodecanoyl-4,6,6a,7,8,9-hexahydroindolo[4,3-''fg'']quinoline-9-carboxamide | image = 1DD-LSD_structure.png | width = 220 <!--Clinical data--> | tradename = | legal_AU = | legal_BR = | legal_CA = | legal_DE = | legal_UK = | legal_US = | legal_US_comment = | legal_status = | routes_of_administration = <!--Identifiers--> | CAS_number = | PubChem = | ChemSpiderID = | UNII...'
 
No edit summary
Line 23: Line 23:


<!--Chemical data-->
<!--Chemical data-->
| C= | H= | N=3 | O=2
| C=32 | H=47 | N=3 | O=2
| smiles =
| smiles =
| StdInChI =
| StdInChI =

Revision as of 07:53, 7 May 2024

1DD-LSD
Identifiers
  • (6aR,9R)-N,N-diethyl-6-methyl-4-dodecanoyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
Chemical and physical data
FormulaC32H47N3O2
Molar mass505.747 g·mol−1

1DD-LSD (N1-dodecanoyl-lysergic acid diethylamide) is an acylated derivative of lysergic acid diethylamide (LSD). In animal studies it produces a weak head-twitch response but with 27x lower potency than LSD itself. It is being researched as a potential slow-onset, long lasting prodrug for LSD which is expected to have reduced psychoactive effects.[1]


See also


References

  1. ^ Kavanagh PV, Westphal F, Pulver B, Elliott SP, Stratford A, Halberstadt AL, Brandt SD. Analytical and behavioral characterization of 1-dodecanoyl-LSD (1DD-LSD). Drug Test Anal. 2024 Apr 3. doi:10.1002/dta.3691 PMID 38569566